Upgrades/Downgrades
Updated: 20-Jul-26 16:31 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Methanex | MEOH | CIBC | Neutral » Sector Outperform | $71 | |
| U.S. Bancorp | USB | Evercore ISI | In-line » Outperform | $72 | |
| YETI Holdings | YETI | Goldman | Neutral » Buy | $63 | |
| U.S. Bancorp | USB | JP Morgan | Underweight » Neutral | $67.50 | |
| Urban Outfitters | URBN | Goldman | Neutral » Buy | $93 | |
| Lumentum | LITE | Barclays | Equal Weight » Overweight | $1000 | |
| Harley-Davidson | HOG | Loop Capital | Hold » Buy | $32 | |
| Grupo Aeroportuario del Pacifico | PAC | Citigroup | Neutral » Buy | ||
| Global Payments | GPN | Morgan Stanley | Equal-Weight » Overweight | $100 | |
| Fervo Energy | FRVO | Jefferies | Hold » Buy | $34 | |
| Akari Therapeutics | AKTX | Maxim Group | Hold » Buy | $30 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| NNN REIT | NNN | Morgan Stanley | Overweight » Equal-Weight | $50 | |
| Truist | TFC | JP Morgan | Neutral » Underweight | $53 | |
| StoneX Group | SNEX | Jefferies | Buy » Hold | $112 | |
| Penguin Solutions | PENG | Barclays | Equal Weight » Underweight | $40 | |
| Monster Beverage | MNST | Deutsche Bank | Buy » Hold | $98 | |
| HubSpot | HUBS | Wells Fargo | Overweight » Equal Weight | $225 | |
| F.N.B. Corp | FNB | BofA Securities | Buy » Neutral | $19 | |
| Fidus Investment | FDUS | Keefe Bruyette | Outperform » Mkt Perform | $19.50 | |
| Charles Schwab | SCHW | BMO Capital Markets | Outperform » Market Perform | $105 | |
| Charles River | CRL | CLSA | Outperform » Hold | $219 | |
| Birkenstock Holding Plc | BIRK | Seaport Research Partners | Buy » Neutral | ||
| Allegro Microsystems | ALGM | Barclays | Overweight » Equal Weight | $48 | |
| Travelers | TRV | Goldman | Neutral » Sell | $350 | |
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Neuronetics | STIM | BTIG Research | Buy | $5 | |
| NextNav | NN | Odeon | Buy | $22 | |
| Workday | WDAY | CLSA | Underperform | $92 | |
| Versigent | VGNT | Goldman | Buy | $48 | |
| Trulieve Cannabis Corp. | TRLV | Cantor Fitzgerald | Overweight | $15 | |
| TotalEnergies SE | TTE | Mizuho | Outperform | $103 | |
| SOPHiA GENETICS SA | SOPH | H.C. Wainwright | Buy | $12 | |
| Shell plc | SHEL | Mizuho | Neutral | $98 | |
| Shattuck Labs | STTK | Leerink Partners | Outperform | $16 | |
| ServiceNow | NOW | CLSA | Underperform | $72 | |
| Salesforce | CRM | CLSA | Hold | $165 | |
| Regal Rexnord | RRX | Deutsche Bank | Buy | $286 | |
| Ralliant Corporation | RAL | BMO Capital Markets | Market Perform | $78 | |
| Oracle | ORCL | CLSA | Hold | $145 | |
| Moog | MOG.A | JP Morgan | Overweight | $520 | |
| Microsoft | MSFT | CLSA | Outperform | $535 | |
| Honeywell Aerospace | HONA | UBS | Neutral | $231 | |
| Gloo Holdings | GLOO | Citizens | Mkt Outperform | $8 | |
| Faeth Therapeutics | FTH | Citizens | Mkt Outperform | $51 | |
| Enpro Inc. | NPO | JP Morgan | Overweight | $420 | |
| Eloxx Pharmaceuticals | ELOX | Guggenheim | Buy | $43 | |
| Crane | CR | BMO Capital Markets | Outperform | $253 | |
| Brainsway | BWAY | BTIG Research | Buy | $18 | |
| BP | BP | Mizuho | Outperform | $51 | |
| Apollo Global Management | APO | HSBC Securities | Buy | $145 | |
| Adobe | ADBE | CLSA | Outperform | $300 | |
| Kinetik | KNTK | Tudor, Pickering, Holt & Co. | Buy | $57 | |
| NN Inc | NNBR | Craig Hallum | Buy | $7 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Soluna Holdings | SLNH | H.C. Wainwright | Buy | $4 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| SolarEdge Technologies | SEDG | TD Cowen | Buy | $85 » $75 | |
| Enphase Energy | ENPH | TD Cowen | Hold | $70 » $48 | |
| Nextpower | NXT | TD Cowen | Hold | $135 » $118 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |